Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

CTORCITIUS ONCOLOGY, INC.

Nasdaq · CIK 0001851484
Filer category<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end0930
XBRL facts205

Identity from submissions API

NameCITIUS ONCOLOGY, INC.
CIK0001851484
TickersCTOR
ExchangesNasdaq
Entity typeoperating
Category<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN994362660
LEI—
Fiscal year end0930
State of incorporationDE DE
Phone(908) 967-6677
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • TenX Keane Acquisition (2021-05-19T04:00:00.000Z → 2024-08-05T04:00:00.000Z)
Business address
11 COMMERCE DRIVE
1ST FLOOR
CRANFORD
NJ
07016
NJ
Mailing address
11 COMMERCE DRIVE
FIRST FLOOR
CRANFORD
NJ
07016
NJ

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

280 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-005218 005-93794 261557933 34 10591
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119805 9699
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119803 8389
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119799 5800
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119797 8417
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119782 9675
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119769 9692
2026-11-13 4 xslF345X06/ownership.xml 0001213900-26-119766 9693
2026-11-12 4 xslF345X06/ownership.xml 0001213900-26-119121 14439
2026-11-12 4 xslF345X06/ownership.xml 0001213900-26-119120 9677
2026-11-12 4 xslF345X06/ownership.xml 0001213900-26-119119 9673
2026-11-12 4 xslF345X06/ownership.xml 0001213900-26-119118 9679
2026-11-04 8-K CURRENT REPORT 8.01,9.01 0001213900-26-115964 001-41534 261522872 34 224636 1 1
2026-10-26 8-K CURRENT REPORT 2.02,9.01 0001213900-26-112477 001-41534 261485955 34 247159 1 1
2026-10-23 8-K CURRENT REPORT 8.01 0001213900-26-112109 001-41534 261482307 34 189987 1 1
2026-09-29 8-K CURRENT REPORT 5.07 0001213900-26-104694 001-41534 261424270 34 190932 1 1
2026-08-26 ARS FORM ARS 0001213900-26-093758 001-41534 261317770 34 1008595
2026-08-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-26-093757 001-41534 261317755 34 2149187 1 1
2026-08-14 3 PRIMARY DOCUMENT 0002149660-26-000001 8350
2026-08-14 424B3 PROSPECTUS 0001213900-26-090293 333-288656 261283814 33 471220
2026-08-14 10-Q QUARTERLY REPORT 0001213900-26-090184 001-41534 261282795 34 4501954 1 1
2026-08-14 8-K CURRENT REPORT 2.02,9.01 0001213900-26-090182 001-41534 261282779 34 332498 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-003568 005-93794 261277081 34 10589
2026-08-12 8-K CURRENT REPORT 5.02,9.01 0001213900-26-088068 001-41534 261265438 34 233500 1 1
2026-08-05 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-085679 333-288656 261243718 33 88503
2026-08-05 8-K CURRENT REPORT 8.01,9.01 0001213900-26-085434 001-41534 261241620 34 258711 1 1
2026-06-05 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001912 333-296360 261070909 33 1849
2026-06-04 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-065310 005-93794 261065394 34 9587
2026-06-03 CORRESP filename1.htm 0001213900-26-064738 7411
2026-06-03 UPLOAD filename1.pdf 0000000000-26-005598 333-296360 145296
2026-06-01 424B3 424B3 0001213900-26-063546 333-288656 261051812 33 120232
2026-06-01 8-K CURRENT REPORT 8.01,9.01 0001213900-26-063530 001-41534 261051422 34 293914 1 1
2026-05-29 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001213900-26-062911 001-41534 261045741 34 98677
2026-05-29 S-3 REGISTRATION STATEMENT 0001213900-26-062864 333-296360 261045160 33 528295 1 1
2026-05-22 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-060571 333-288656 261013967 33 386492
2026-05-19 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001213900-26-059053 001-41534 26999293 34 98533
2026-05-15 8-K CURRENT REPORT 2.02,9.01 0001213900-26-057883 001-41534 26989044 34 331153 1 1
2026-05-15 10-Q QUARTERLY REPORT 0001213900-26-057841 001-41534 26988515 34 4168003 1 1
2026-05-15 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002138 005-93794 26984076 34 10585
2026-05-06 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-052840 333-288656 26948992 33 1024439
2026-05-06 8-K CURRENT REPORT 1.01,2.03,3.02,8.01,9.01 0001213900-26-052552 001-41534 26946109 34 1419304 1 1
2026-05-05 424B3 PROSPECTUS SUPPLEMENT 0001213900-26-052124 333-288656 26942446 33 300687
2026-04-29 8-K CURRENT REPORT 8.01,9.01 0001213900-26-049347 001-41534 26917107 34 267808 1 1
2026-04-28 8-K CURRENT REPORT 3.01 0001213900-26-048629 001-41534 26908966 34 192312 1 1
2026-03-31 8-K CURRENT REPORT 8.01,9.01 0001213900-26-037501 001-41534 26822449 34 261445 1 1
2026-03-10 8-K CURRENT REPORT 8.01,9.01 0001213900-26-025464 001-41534 26737444 34 261980 1 1
2026-03-04 8-K CURRENT REPORT 8.01,9.01 0001213900-26-023440 001-41534 26719097 34 283581 1 1
2026-03-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000698 333-288656 26710920 33 1861
2026-02-20 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 0001213900-26-018829 333-288656 26660437 33 6974341 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-26-001261 005-93794 26645122 34 10647
2026-02-13 8-K CURRENT REPORT 2.02,9.01 0001213900-26-015894 001-41534 26629044 34 302142 1 1
2026-02-13 10-Q QUARTERLY REPORT 0001213900-26-015877 001-41534 26628958 34 3841180 1 1
2026-01-29 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001213900-26-009524 001-41534 26578518 34 108816
2026-01-20 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001213900-26-005689 001-41534 26543338 34 110659
2026-01-12 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000150 333-292577 26528330 33 1848
2026-01-09 CORRESP filename1.htm 0001213900-26-002941 7228
2026-01-09 UPLOAD filename1.pdf 0000000000-26-000285 333-292577 40149
2026-01-05 S-3 REGISTRATION STATEMENT 0001213900-26-001187 333-292577 26506793 33 381293 1 1
2025-12-23 8-K CURRENT REPORT 2.02,9.01 0001213900-25-125418 001-41534 251601379 34 296757 1 1
2025-12-23 10-K ANNUAL REPORT 0001213900-25-125331 001-41534 251600861 34 4872960 1 1
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124537 5252
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124536 5273
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124534 5279
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124535 5283
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124533 5285
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124532 5234
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124531 5251
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124530 5232
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124529 5258
2025-12-22 4/A OWNERSHIP DOCUMENT 0001213900-25-124528 5234
2025-12-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-122793 005-93794 251579373 34 8035
2025-12-10 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-25-120197 001-41534 251562884 34 1319550 1 1
2025-12-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-119760 333-289979 251560181 33 435235
2025-12-01 8-K CURRENT REPORT 7.01,8.01,9.01 0001213900-25-116764 001-41534 251540635 34 15368117 1 1
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116682 5165
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116680 5163
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116681 5183
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116679 5182
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116677 5214
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116678 5204
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116676 5165
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116674 5189
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116675 5216
2025-12-01 4/A xslF345X05/ownership.xml 0001213900-25-116673 5210
2025-11-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001172661-25-005175 005-93794 251488774 34 10645
2025-10-27 8-K CURRENT REPORT 5.02,5.07,9.01 0001213900-25-102625 001-41534 251420238 34 207306 1 1
2025-10-23 8-K FORM 8-K 7.01,9.01 0001213900-25-101737 001-41534 251413771 34 15399481 1 1
2025-09-26 DEF 14A DEFINITIVE PROXY STATEMENT 0001213900-25-092369 001-41534 251350975 34 6348230 1 1
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090617 11815
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090615 6789
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090614 8435
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090613 8093
2025-09-23 4 xslF345X05/ownership.xml 0001213900-25-090611 8397
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090612 8092
2025-09-23 4 OWNERSEHIP DOCUMENT 0001213900-25-090609 8434
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090608 6786
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090616 8099
2025-09-23 4 OWNERSHIP DOCUMENT 0001213900-25-090610 8075
2025-09-19 S-8 REGISTRATION STATEMENT 0001213900-25-089630 333-290417 251327623 33 215020 1 1
2025-09-19 8-K CURRENT REPORT 3.02,5.02,9.01 0001213900-25-089615 001-41534 251327529 34 201110 1 1
2025-09-12 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-087227 005-93794 251311664 34 8044
2025-09-10 424B3 PROSPECTUS 0001213900-25-086584 333-289979 251306486 33 155859
2025-09-10 8-K CURRENT REPORT 1.01,3.02,8.01,9.01 0001213900-25-086568 001-41534 251306373 34 959335 1 1
2025-09-10 424B5 PROSPECTUS SUPPLEMENT 0001213900-25-086384 333-289979 251304736 33 375044
2025-09-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002843 333-289979 251294922 33 1849
2025-09-02 CORRESP filename1.htm 0001213900-25-082978 7659
2025-09-02 S-3 REGISTRATION STATEMENT 0001213900-25-082919 333-289979 251283004 33 1048374 1 1
2025-08-22 UPLOAD filename1.pdf 0000000000-25-009017 377-08347 40485
2025-08-20 DRS filename1.htm 0001213900-25-078919 377-08347 251236022 33 461569
2025-08-18 8-K CURRENT REPORT 8.01 0001213900-25-078018 001-41534 251228934 34 189145 1 1
2025-08-18 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-078016 333-288656 251228924 33 301334
2025-08-12 8-K CURRENT REPORT 2.02,9.01 0001213900-25-075014 001-41534 251207495 34 274920 1 1
2025-08-12 10-Q QUARTERLY REPORT 0001213900-25-074992 001-41534 251207239 34 2750438 1 1
2025-08-07 4 xslF345X05/ownership.xml 0001213900-25-073136 6472
2025-07-25 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-067797 005-93794 251152258 34 6749
2025-07-18 8-K CURRENT REPORT 1.01,8.01,9.01 0001213900-25-065334 001-41534 251132637 34 1051097 1 1
2025-07-17 424B4 PROSPECTUS 0001213900-25-064848 333-288656 251128718 33 1082848
2025-07-16 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002269 333-288656 251128741 33 1849
2025-07-15 CORRESP filename1.htm 0001213900-25-064047 13411
2025-07-14 S-1/A AMENDMENT NO. 1 TO FORM S-1 0001213900-25-063793 333-288656 251122460 33 4424169 1 1
2025-07-14 S-1 REGISTRATION STATEMENT 0001213900-25-063483 333-288656 251120212 33 5389680 1 1
2025-06-27 8-K CURRENT REPORT 8.01 0001213900-25-059084 001-41534 251087447 34 187974 1 1
2025-06-17 8-K CURRENT REPORT 8.01,9.01 0001213900-25-055182 001-41534 251053317 34 251633 1 1
2025-05-14 10-Q QUARTERLY REPORT 0001213900-25-043359 001-41534 25946287 34 2498419 1 1
2025-05-14 8-K CURRENT REPORT 2.02,9.01 0001213900-25-043363 001-41534 25946274 34 281472 1 1
2025-05-01 UPLOAD filename1.pdf 0000000000-25-004655 377-07955 40399
2025-04-28 DRS filename1.htm 0001213900-25-036067 377-07955 25880314 33 1187548
2025-04-25 8-K FORM 8-K 3.01 0001213900-25-035575 001-41534 25874230 34 199254 1 1
2025-04-03 8-K CURRENT REPORT 1.01,9.01 0001213900-25-028621 001-41534 25809636 34 202903 1 1
2025-02-24 DEFA14C DEFINITIVE ADDITIONAL MATERIALS 0001213900-25-016642 001-41534 25657504 34 13399
2025-02-24 DEF 14C DEFINITIVE INFORMATION STATEMENT 0001213900-25-016636 001-41534 25657464 34 83324
2025-02-14 8-K CURRENT REPORT 8.01,9.01 0001213900-25-014351 001-41534 25630167 34 294667 1 1
2025-02-14 10-Q QUARTERLY REPORT 0001213900-25-014320 001-41534 25629662 34 2437303 1 1
2025-02-12 PRE 14C PRELIMINARY INFORMATION STATEMENT 0001213900-25-012917 001-41534 25615269 34 116177
2025-02-06 8-K CURRENT REPORT 8.01,9.01 0001213900-25-010748 001-41534 25595694 34 259922 1 1
2025-01-27 10-K/A AMENDMENT NO. 1 TO FORM 10-K 0001213900-25-007012 001-41534 25559429 34 478320 1 1
2025-01-07 8-K CURRENT REPORT 8.01,9.01 0001213900-25-001407 001-41534 25513584 34 260778 1 1
2025-01-06 8-K CURRENT REPORT 8.01,9.01 0001213900-25-000953 001-41534 25509142 34 239915 1 1
2024-12-27 8-K CURRENT REPORT 2.02,9.01 0001213900-24-113159 001-41534 241586280 34 306964 1 1
2024-12-27 10-K ANNUAL REPORT 0001213900-24-113150 001-41534 241586208 34 3901304 1 1
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109376 5566
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109305 6856
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109304 9639
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109301 5569
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109300 6839
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109299 6861
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109298 6871
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109295 7215
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109293 7215
2024-12-16 4 xslF345X05/ownership.xml 0001213900-24-109292 7211
2024-11-12 8-K CURRENT REPORT 8.01,9.01 0001213900-24-096269 001-41534 241443737 34 273404 1 1
2024-11-06 SC 13G/A CTOR 13G/A 0002033916-24-000020 005-93794 241432138 34 54791
2024-09-13 8-K CURRENT REPORT 1.01 0001213900-24-078287 001-41534 241296505 34 200161 1 1
2024-09-05 8-K CURRENT REPORT 8.01,9.01 0001213900-24-076111 001-41534 241281594 34 254444 1 1
2024-09-05 SC 13G/A SC 13G/A 0001140361-24-040170 005-93794 241280137 34 161938
2024-08-30 4/A xslF345X05/ownership.xml 0001213900-24-074519 6135
2024-08-30 4/A xslF345X05/ownership.xml 0001213900-24-074518 6098
2024-08-30 4/A xslF345X05/ownership.xml 0001213900-24-074517 6131
2024-08-30 4/A xslF345X05/ownership.xml 0001213900-24-074516 6135
2024-08-26 8-K/A AMENDMENT NO. 1 TO FORM 8-K 2.01,9.01 0001213900-24-072598 001-41534 241241471 34 699247 1 1
2024-08-16 8-K CURRENT REPORT 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.06,9.01 0001213900-24-070335 001-41534 241217674 34 947204 1 1
2024-08-16 SC 13D SCHEDULE 13D 0001213900-24-070284 005-93794 241217172 34 814627
2024-08-16 4 xslF345X05/ownership.xml 0001213900-24-070240 5539
2024-08-16 3 xslF345X02/ownership.xml 0001213900-24-070238 9541
2024-08-15 SC 13D/A formsc13da.htm 0001493152-24-032563 005-93794 241211391 34 1086885
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069251 11545
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069250 11885
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069249 5876
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069248 11848
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069247 11749
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069246 11287
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069245 10951
2024-08-14 4 xslF345X05/ownership.xml 0001213900-24-069244 11909
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069243 8973
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069242 9548
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069241 9463
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069240 9120
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069238 9610
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069236 8963
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069235 8970
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069234 11431
2024-08-14 3 xslF345X02/ownership.xml 0001213900-24-069233 9415
2024-08-13 25-NSE xslF25X02/primary_doc.xml 0001354457-24-000565 333-256271 241202240 34 3107
2024-08-09 10-Q form10-q.htm 0001493152-24-030991 001-41534 241193131 34 3706827 1 1
2024-08-05 8-K form8-k.htm 5.02,5.07,8.01,9.01 0001493152-24-030145 001-41534 241172840 34 569094 1 1
2024-07-19 425 form425.htm 0001493152-24-028501 001-41534 241127702 34 72062
2024-07-19 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-028500 001-41534 241127697 34 316345 1 1
2024-07-12 SEC STAFF LETTER filename1.pdf 9999999997-24-003213 63490
2024-07-12 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-07-12 16:30:00 9999999995-24-002146 333-275506 241115741 33 1761
2024-07-12 424B3 form424b3.htm 0001493152-24-027130 333-275506 241115289 33 7604884
2024-07-11 CORRESP filename1.htm 0001493152-24-026942 13178
2024-07-11 S-4/A forms-4a.htm 0001493152-24-026940 333-275506 241111990 33 162743
2024-07-11 S-4/A forms-4a.htm 0001493152-24-026883 333-275506 241110996 33 17841766 1 1
2024-06-18 425 form425.htm 0001493152-24-024237 001-41534 241050914 34 69014
2024-06-18 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-024236 001-41534 241050905 34 313325 1 1
2024-06-17 S-4/A forms-4a.htm 0001493152-24-024182 333-275506 241049439 33 14374293 1 1
2024-06-17 CORRESP filename1.htm 0001493152-24-024184 31445
2024-06-06 425 form425.htm 0001493152-24-022978 001-41534 241026525 34 32880
2024-06-06 8-K form8-k.htm 8.01 0001493152-24-022977 001-41534 241026522 34 273219 1 1
2024-05-21 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-020866 001-41534 24968833 34 318625 1 1
2024-05-20 10-Q form10-q.htm 0001493152-24-020783 001-41534 24965975 34 3425534 1 1
2024-05-17 UPLOAD filename1.pdf 0000000000-24-005783 333-275506 46180
2024-05-15 NT 10-Q formnt10-q.htm 0001493152-24-019894 001-41534 24951310 34 34660
2024-05-03 CORRESP filename1.htm 0001493152-24-017755 93352
2024-05-03 S-4/A forms-4a.htm 0001493152-24-017749 333-275506 24914254 33 13161070 1 1
2024-04-29 425 form425.htm 0001493152-24-017026 001-41534 24891982 34 67396
2024-04-29 8-K form8-k.htm 1.01,2.03,9.01 0001493152-24-017024 001-41534 24891967 34 314825 1 1
2024-04-16 10-K form10-k.htm 0001493152-24-014850 001-41534 24848552 34 4077620 1 1
2024-04-02 NT 10-K formnt10-k.htm 0001493152-24-012662 001-41534 24812683 34 31889
2024-03-07 SC 13G/A KARPUS INVESTMENT MGT / TENX KEANE ACQUISITION - SCHEDULE 13G/A(#1E) 0001072613-24-000323 005-93794 24730078 34 76852
2024-02-13 SC 13G SC 13G 0001193125-24-034270 005-93794 24631311 34 61957
2024-02-13 UPLOAD filename1.pdf 0000000000-24-001725 333-275506 58900
2024-02-13 SC 13G KARPUS INVESTMENT MGT / TENX KEANE ACQUISITION - SCHEDULE 13G 0001072613-24-000218 005-93794 24625843 34 76903
2024-02-08 SC 13G SC 13G 0001140361-24-006409 005-93794 24609066 34 162734
2024-02-05 SC 13G/A tenku13gamend.txt 0001846718-24-000023 005-93794 24595530 34 7541
2024-01-30 CORRESP filename1.htm 0001493152-24-004362 163933
2024-01-30 S-4/A forms-4a.htm 0001493152-24-004360 333-275506 24579699 33 14207124 1 1
2024-01-19 UPLOAD filename1.pdf 0000000000-24-000736 001-41534 39849
2024-01-18 8-K form8-k.htm 1.01,2.03,5.03,5.07,8.01,9.01 0001493152-24-002896 001-41534 24541753 34 1483563 1 1
2024-01-10 8-K form8-k.htm 8.01,9.01 0001493152-24-001958 001-41534 24527054 34 1482978 1 1
2024-01-10 DEFA14A formdefa14a.htm 0001493152-24-001930 001-41534 24526381 34 1100034
2024-01-08 DEF 14A formdef14a.htm 0001493152-24-001720 001-41534 24520779 34 1229560
2023-12-28 PRE 14A formpre14a.htm 0001493152-23-046348 001-41534 231521199 34 1221705
2023-12-14 SEC STAFF LETTER filename1.pdf 9999999997-23-004771 65262
2023-12-14 UPLOAD filename1.pdf 0000000000-23-013614 333-275506 82415
2023-11-20 10-Q form10-q.htm 0001493152-23-042170 001-41534 231423708 34 3448085 1 1
2023-11-14 NT 10-Q formnt10-q.htm 0001493152-23-041244 001-41534 231407623 34 33911
2023-11-13 S-4 forms-4.htm 0001493152-23-040532 333-275506 231399152 33 16221728 1 1
2023-10-24 425 form425.htm 0001493152-23-038046 001-41534 231341181 34 16797601
2023-10-24 8-K form8-k.htm 1.01,7.01,9.01 0001493152-23-038045 001-41534 231341178 34 17262417 1 1
2023-10-18 8-K form8-k.htm 1.01,2.03,3.02,8.01,9.01 0001493152-23-037635 001-41534 231332886 34 353714 1 1
2023-08-16 10-Q form10-q.htm 0001493152-23-029131 001-41534 231177888 34 3292610 1 1
2023-08-15 NT 10-Q formnt10-q.htm 0001493152-23-028718 001-41534 231172729 34 30758
2023-07-18 8-K form8-k.htm 1.01,2.03,3.02,8.01,9.01 0001493152-23-024835 001-41534 231094420 34 348041 1 1
2023-05-15 10-Q form10-q.htm 0001493152-23-017394 001-41534 23922765 34 2980121 1 1
2023-04-17 10-K form10-k.htm 0001493152-23-012545 001-41534 23824183 34 3559255 1 1
2023-03-31 NT 10-K formnt10-k.htm 0001493152-23-010326 001-41534 23788273 34 30771
2023-02-14 SC 13G/A SCHEDULE 13G/A 0001376474-23-000130 005-93794 23628000 34 43163
2023-02-10 SC 13G TENK 13G 0001393825-23-000168 005-93794 23612754 34 61380
2023-02-08 SC 13G/A SCHEDULE 13G/A 0001376474-23-000107 005-93794 23597211 34 43160
2023-02-08 SC 13G/A TENKU13GAMEND 0001846718-23-000039 005-93794 23596657 34 7338
2022-12-06 8-K from8-k.htm 8.01,9.01 0001493152-22-034614 001-41534 221448493 34 286194 1 1
2022-11-28 10-Q form10-q.htm 0001493152-22-033847 001-41534 221426277 34 2729747 1 1
2022-10-28 SC 13D formsc13d.htm 0001493152-22-029872 005-93794 221342745 34 81253
2022-10-24 8-K form8-k.htm 8.01,9.01 0001493152-22-029450 001-41534 221326639 34 155127
2022-10-20 SC 13G SCHEDULE 13G 0001376474-22-000427 005-93794 221320349 34 43059
2022-10-19 8-K form8-k.htm 1.01,3.02,5.03,8.01,9.01 0001493152-22-028873 001-41534 221318658 34 1907166
2022-10-19 SC 13G tenku13ginitial.txt 0001846718-22-000116 005-93794 221318609 34 7300
2022-10-14 424B4 form424b4.htm 0001493152-22-028441 333-256271 221311166 33 1747663
2022-10-13 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2022-10-13 17:00:00 9999999995-22-003025 333-256271 221310166 33 1686
2022-10-13 3 xslF345X02/ownership.xml 0001493152-22-028364 2837
2022-10-13 3 xslF345X02/ownership.xml 0001493152-22-028363 2849
2022-10-13 3 xslF345X02/ownership.xml 0001493152-22-028361 6286
2022-10-13 3 xslF345X02/ownership.xml 0001493152-22-028358 4757
2022-10-13 3 xslF345X02/ownership.xml 0001493152-22-028357 2908
2022-10-13 CERT 8A_Cert_TENK.pdf 0001354457-22-000571 001-41534 221308671 34 138195
2022-10-13 8-A12B form8-a12b.htm 0001493152-22-028299 001-41534 221308020 34 25024
2022-10-11 CORRESP filename1.htm 0001493152-22-028092 12565
2022-10-11 CORRESP filename1.htm 0001493152-22-028093 11810
2022-09-12 S-1/A forms-1a.htm 0001493152-22-025658 333-256271 221239299 33 4355151
2022-07-29 CORRESP filename1.htm 0001493152-22-020687 60741
2022-07-29 S-1/A forms-1a.htm 0001493152-22-020683 333-256271 221120522 33 1843541
2022-07-26 UPLOAD filename1.pdf 0000000000-22-007812 53107
2022-05-24 S-1/A forms-1a.htm 0001493152-22-014854 333-256271 22953695 33 1740945
2022-05-12 CORRESP filename1.htm 0001493152-22-013077 11444
2022-05-12 CORRESP filename1.htm 0001493152-22-013073 12718
2022-05-11 S-1/A forms-1a.htm 0001493152-22-012880 333-256271 22914786 33 1714074
2022-05-11 CORRESP filename1.htm 0001493152-22-012760 11044
2022-05-11 CORRESP filename1.htm 0001493152-22-012759 11402
2022-04-01 S-1/A forms-1a.htm 0001493152-22-008828 333-256271 22798682 33 580975
2022-03-08 CORRESP filename1.htm 0001493152-22-006317 40093
2022-03-08 S-1/A forms-1a.htm 0001493152-22-006313 333-256271 22722673 33 4684607
2021-09-14 UPLOAD filename1.pdf 0000000000-21-011107 57193
2021-08-20 CORRESP filename1.htm 0001493152-21-020863 20364
2021-08-20 S-1/A forms-1a.htm 0001493152-21-020860 333-256271 211194723 33 4638327
2021-07-19 UPLOAD filename1.pdf 0000000000-21-008902 44590
2021-06-30 S-1/A forms-1a.htm 0001493152-21-015601 333-256271 211059425 33 1905331
2021-06-29 CORRESP filename1.htm 0001493152-21-015602 21380
2021-06-16 UPLOAD filename1.pdf 0000000000-21-007413 44742
2021-05-19 S-1 forms-1.htm 0001493152-21-012185 333-256271 21937738 33 2766844

Latest XBRL company facts

One latest value per concept from companyfacts (205 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 92.98M 2026-08-13 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
dei EntityListingParValuePerShare Entity Listing, Par Value Per Share USD/shares 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
dei EntityPublicFloat Entity Public Float USD 5.10M 2025-03-31 2025 FY 10-K 2025-12-23 0001213900-25-125331
ffd NetFeeAmt NetFeeAmt USD 3,820.18 2026-05-19 S-3 2026-05-29 0001213900-26-062864
ffd TtlFeeAmt TtlFeeAmt USD 3,820.18 2026-05-19 S-3 2026-05-29 0001213900-26-062864
ffd TtlOfferingAmt TtlOfferingAmt USD 27.66M 2026-05-19 S-3 2026-05-29 0001213900-26-062864
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-05-19 S-3 2026-05-29 0001213900-26-062864
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-05-19 S-3 2026-05-29 0001213900-26-062864
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 7.32M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AccountsPayableCurrentAndNoncurrent Accounts Payable USD 2.20M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 686,235 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 25.84M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AccruedLiabilitiesCurrentAndNoncurrent Accrued Liabilities USD 4.06M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 145.48M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AdjustmentForAmortization Amortization USD 179,492 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 37.01M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 3.56M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 343,845 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 8.12M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap AllowanceForDoubtfulAccountsReceivableCurrent Accounts Receivable, Allowance for Credit Loss, Current USD 0 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 179,492 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap Assets Assets USD 112.09M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap AssetsCurrent Assets, Current USD 42.71M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 110.00M 2023-04-29 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap Cash Cash USD 16.56M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 16.56M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 16.56M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 112 2025-03-31 2025 Q2 10-Q 2025-05-14 0001213900-25-043359
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD 12.64M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -32,485 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 1.09 2025-12-10 2026 Q2 10-Q 2026-05-15 0001213900-26-057841
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight Class of Warrant or Right, Number of Securities Called by Each Warrant or Right shares 12.78M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 25.56M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 53.95M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 98.95M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockOtherSharesOutstanding Common Stock, Other Shares, Outstanding shares 100 2023-07-05 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 105.76M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 105.76M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CommonStockValue Common Stock, Value, Issued USD 10,576 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 4.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap CostOfRevenue Cost of Revenue USD 1.61M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 10.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 3.80M 2024-08-16 2025 Q1 10-Q 2025-02-14 0001213900-25-014320
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 169,252 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057841
us-gaap DeferredFinanceCostsNet Debt Issuance Costs, Net USD 250,000 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DeferredFinanceCostsNoncurrentNet Debt Issuance Costs, Noncurrent, Net USD 3.59M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -74,317 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 2.78M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 2.71M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 3.19M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 12.72M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsResearch Deferred Tax Assets, Tax Credit Carryforwards, Research USD 1.58M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.93M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 19.42M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 2.78M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 2.78M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 130,687 2021-12-31 2022 FY 10-K 2023-04-17 0001493152-23-012545
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -0.42 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -0.42 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.045 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.262 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.071 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure -0.21 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap EmployeeBenefitsAndShareBasedCompensation Employee Benefits and Share-based Compensation USD 1.09M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 7.81M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ExcessStockSharesOutstanding Excess Stock, Shares Outstanding shares 71.55M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 749,280 2026-05-05 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 6.41M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 30.70M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap GrossProfit Gross Profit USD 5.50M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -41.14M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -74,317 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -11.74M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -5.92M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 686,235 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 19.98M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD 126,422 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap IncreaseDecreaseInDueToOtherRelatedPartiesCurrent Increase (Decrease) in Due to Other Related Parties, Current USD 2.31M 2024-10-01 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014320
us-gaap IncreaseDecreaseInDueToRelatedParties Increase (Decrease) in Due to Related Parties USD 471,787 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD 339,252 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 1.50M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InterestExpense Interest Expense USD 218,032 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap InterestExpenseDebt Interest Expense, Debt USD 198,333 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 310,604 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InterestExpenseOther Interest Expense, Other USD 1.80M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 212,794 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 15.67M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InventoryFinishedGoodsNetOfReserves Inventory, Finished Goods, Net of Reserves USD 8.96M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap InventoryNet Inventory, Net USD 22.63M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 6.95M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap InventoryWorkInProcessNetOfReserves Inventory, Work in Process, Net of Reserves USD 8.25M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 168,857 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap LegalFees Legal Fees USD 207,551 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap Liabilities Liabilities USD 71.71M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 112.09M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap LiabilitiesCurrent Liabilities, Current USD 58.79M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap LongTermInvestments Long-term Investments USD 49.15M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap LongTermNotesPayable Notes Payable, Noncurrent USD 6.41M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap LongTermPurchaseCommitmentAmount Long-term Purchase Commitment, Amount USD 17.10M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 33.54M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -7.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -13.90M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -41.07M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NoncashMergerRelatedCosts Noncash Merger Related Costs USD 2.75M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 1.44M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap NotesPayableCurrent Notes Payable, Current USD 1.72M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap NumberOfOperatingSegments Number of Operating Segments pure 1 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap NumberOfReportableSegments Number of Reportable Segments pure 1 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap OperatingExpenses Operating Expenses USD 48.08M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -42.58M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap OtherAssets Other Assets USD 71.28M 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057841
us-gaap OtherCommitment Other Commitment USD 4.50M 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap OtherExpenses Other Expenses USD 83,817 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 2.07M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap OtherLiabilities Other Liabilities USD 559,015 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 349,975 2023-06-30 2023 Q2 10-Q 2023-08-16 0001493152-23-029131
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 221,107 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057841
us-gaap OtherResearchAndDevelopmentExpense Other Research and Development Expense USD 1.21M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsForDeposits Payments for Deposits USD 66,667 2024-04-26 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap PaymentsForFees Payments for Other Fees USD 1.06M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsForLoans Payments for Loans USD 10.00M 2026-05-06 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 2.92M 2022-10-18 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap PaymentsOfFinancingCosts Payments of Financing Costs USD 892,551 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsOfMergerRelatedCostsFinancingActivities Payments of Merger Related Costs, Financing Activities USD 2.75M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap PaymentsToAcquireInProcessResearchAndDevelopment Payments to Acquire in Process Research and Development USD 40.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 7.00M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PaymentsToAcquireOtherInvestments Payments to Acquire Other Investments USD 400,001 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap PreferredStockConvertibleConversionPrice PreferredStockConvertibleConversionPrice USD/shares 0.9 2026-05-04 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap PrepaidAdvertising Prepaid Advertising USD 300,000 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 2.83M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProceedsFromContributedCapital Proceeds from Contributed Capital USD 3.83M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ProceedsFromDebtNetOfIssuanceCosts Proceeds from Debt, Net of Issuance Costs USD 2.36M 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 7.55M 2025-07-17 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 15.06M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 135,000 2025-12-01 2025-12-31 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 9.73M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 9.63M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 25,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 525,311 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 9.70M 2026-05-05 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ProductionAndDistributionCosts Production and Distribution Costs USD 17.30M 2023-10-01 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap PurchaseCommitmentRemainingMinimumAmountCommitted Purchase Commitment, Remaining Minimum Amount Committed USD 16.20M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap PurchaseObligationDueInNextTwelveMonths Purchase Obligation, to be Paid, Year One USD 4.00M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap PurchaseObligationDueInSecondYear Purchase Obligation, to be Paid, Year Two USD 1.60M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap PurchaseObligationDueInThirdYear Purchase Obligation, to be Paid, Year Three USD 1.60M 2024-12-31 2025 Q1 10-Q 2025-02-14 0001213900-25-014320
us-gaap PurchaseObligationFutureMinimumPaymentsRemainderOfFiscalYear Purchase Obligation, to be Paid, Remainder of Fiscal Year USD 4.50M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements Recorded Unconditional Purchase Obligation, Amount of Maturities and Sinking Fund Requirements USD 19.73M 2026-03-31 2026 Q2 10-Q 2026-05-15 0001213900-26-057841
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 50.00M 2024-08-16 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 130,687 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 2.32M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -105.11M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap Revenues Revenues USD 7.11M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 1.75 2025-09-10 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 11.04M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 11.60M 2025-09-19 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price USD/shares 0.8 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.85 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.047 2023-10-01 2024-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 13.10M 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 11.32M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 1.9 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 400,000 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 2.02 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 333,333 2024-10-01 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.75M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.8 2024-10-01 2025-06-30 2025 Q3 10-Q 2025-08-12 0001213900-25-074992
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 5.39M 2025-09-29 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 18.10M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 1.83 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value USD 1.14M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 1.75 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 1.07 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap SharePrice Share Price USD/shares 10 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 1.66 2024-09-30 2024 FY 10-K 2024-12-27 0001213900-24-113150
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsAmount Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Share Value, Amount USD 66.00M 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares Financial Instruments Subject to Mandatory Redemption, Settlement Terms, Number of Shares shares 4.31M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 40.38M 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap StockIssuedDuringPeriodSharesIssuedForServices Stock Issued During Period, Shares, Issued for Services shares 6.65M 2024-01-17 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap StockIssuedDuringPeriodSharesShareBasedCompensationForfeited Shares Issued, Shares, Share-based Payment Arrangement, Forfeited shares 225,000 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 2.29M 2024-01-17 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 749,280 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 3.94M 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 25,000 2022-01-01 2022-12-31 2023 FY 10-K 2024-04-16 0001493152-24-014850
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 49.15M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 11.35 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 2.34M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 2.34M 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2024-06-30 2024 Q2 10-Q 2024-08-09 0001493152-24-030991
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued USD 0 2023-09-30 2023 Q3 10-Q 2023-11-20 0001493152-23-042170
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 7.68M 2024-10-01 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap WarrantExercisePriceDecrease Warrant, Exercise Price, Decrease USD/shares 0.9 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap WarrantExercisePriceIncrease Warrant, Exercise Price, Increase USD/shares 0.9 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 6.13M 2025-09-30 2025 FY 10-K 2025-12-23 0001213900-25-125331
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 98.41M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 98.41M 2025-10-01 2026-06-30 2026 Q3 10-Q 2026-08-14 0001213900-26-090184

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →